Proteome Sciences PLC (PRM) — Capital Reinvestment Ratio
Proteome Sciences PLC (PRM) has a Capital Reinvestment Ratio of 0.05x as of December 2025, meaning it reinvests 0% of its operating cash flow (GBX851.00K) in capital expenditures (GBX39.00K). See PRM equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Proteome Sciences PLC Capital Reinvestment Ratio (2010–2022)
This chart tracks Proteome Sciences PLC's Capital Reinvestment Ratio across 6 annual periods. Check PRM cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Proteome Sciences PLC (2010–2022)
Year-by-year Capital Reinvestment Ratio for Proteome Sciences PLC from 2010 to 2022. For live market cap and broader valuation context, see PRM market cap overview.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 815.89x | GBX2.14 Million | GBX1.75 Billion | ▼ -62.4% |
| 2021 | 2168.98x | GBX793.00K | GBX1.72 Billion | ▲ +159.3% |
| 2020 | 836.39x | GBX1.58 Million | GBX1.32 Billion | ▲ +3186498.5% |
| 2017 | 0.03x | GBX55.47 Billion | GBX1.46 Billion | ▼ -36.5% |
| 2015 | 0.04x | GBX46.63 Billion | GBX1.93 Billion | ▼ -73.8% |
| 2010 | 0.16x | GBX4.00 Million | GBX631.00K | — |